Cardiovascular Disease (CVD) Risk Assessment and Lipid Lowering Treatment in Type 2 Diabetes Mellitus Patients Treated at Secondary and/or Tertiary Hospitals in Korea
Not Applicable
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0004984
- Lead Sponsor
- Pfizer Upjohn Korea
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
1. Adult Type 2 diabetes mellitus patients (=20 years) treated at secondary and/or tertiary hospitals
2. Patients with a record on cholesterol level at the time of enrollment
Exclusion Criteria
1. Patients currently participating in other drug-controlled interventional study
2. Patients in severe or unstable medical conditions by physicians’ discretion during the recruitment
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the risks of cardiovascular diseases;lipid lowering treatments;the concordance with clinical practice guidelines
- Secondary Outcome Measures
Name Time Method the lipid lowering treatment modifications